Abstract 357: Pan-HER, an antibody mixture simultaneously targeting EGFR, HER2, and HER3, is highly effective in triple negative breast cancer patient-derived xenografts
2019 ◽
2018 ◽
Vol 144
(3)
◽
pp. 651-664
◽
2015 ◽
2017 ◽